Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CHLORPROMAZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 35189.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 06, 2020, and payment made on September 28, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II